Fundament and Prerequisites for the Application of an Antifungal TDM Service

por Brüggemann, Roger J. M., Aarnoutse, Rob E.
Publicado 2015

Precision Therapy for Invasive Fungal Diseases

por Märtson, Anne-Grete, Alffenaar, Jan-Willem C., Brüggemann, Roger J., Hope, William
Publicado 2021

A rare case of supraspinatus tendon rupture

por Strobbe, Leonie, Brüggemann, Roger J. M., Donnelly, Peter J., Blijlevens, Nicole M. A.
Publicado 2011

High Variability in Isavuconazole Unbound Fraction in Clinical Practice: A Call to Reconsider Pharmacokinetic/Pharmacodynamic Targets and Breakpoints

por Jansen, Anouk M. E., ter Heine, Rob, Verweij, Paul E., Brüggemann, Roger J. M.
Publicado 2023

Normal fat mass cannot be reliably estimated in typical pharmacokinetic studies

por Wasmann, Roeland E., Svensson, Elin M., Schalkwijk, Stein J., Brüggemann, Roger J., ter Heine, Rob
Publicado 2020

Repurposing antifungals: population pharmacokinetics of itraconazole and hydroxy-itraconazole following administration of a nanocrystal formulation

por Jansen, Anouk M E, Ter Heine, Rob, Donnelly, J P, Blijlevens, Nicole, Brüggemann, Roger J M
Publicado 2023

Dosing Recommendations for Vancomycin in Children and Adolescents with Varying Levels of Obesity and Renal Dysfunction: a Population Pharmacokinetic Study in 1892 Children Aged 1–1...

por Smit, Cornelis, Goulooze, Sebastiaan C., Brüggemann, Roger J. M., Sherwin, Catherine M., Knibbe, Catherijne A. J.
Publicado 2021

Clinical Pharmacokinetics of Triazoles in Pediatric Patients

por Bury, Didi, Tissing, Wim J. E., Muilwijk, Eline W., Wolfs, Tom F. W., Brüggemann, Roger J.
Publicado 2021

Cost Evaluation of Dried Blood Spot Home Sampling as Compared to Conventional Sampling for Therapeutic Drug Monitoring in Children

por Martial, Lisa C., Aarnoutse, Rob E., Schreuder, Michiel F., Henriet, Stefanie S., Brüggemann, Roger J. M., Joore, Manuela A.
Publicado 2016

Clinical Pharmacokinetics and Pharmacodynamics of Micafungin

por Wasmann, Roeland E., Muilwijk, Eline W., Burger, David M., Verweij, Paul E., Knibbe, Catherijne A., Brüggemann, Roger J.
Publicado 2017

Pharmacokinetics and Target Attainment of Antibiotics in Critically Ill Children: A Systematic Review of Current Literature

por Hartman, Stan J. F., Brüggemann, Roger J., Orriëns, Lynn, Dia, Nada, Schreuder, Michiel F., de Wildt, Saskia N.
Publicado 2019

Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B

por Adler-Moore, Jill, Lewis, Russell E, Brüggemann, Roger J M, Rijnders, Bart J A, Groll, Andreas H, Walsh, Thomas J
Publicado 2019

Clinical Pharmacokinetics, Pharmacodynamics, Safety and Efficacy of Liposomal Amphotericin B

por Groll, Andreas H, Rijnders, Bart J A, Walsh, Thomas J, Adler-Moore, Jill, Lewis, Russell E, Brüggemann, Roger J M
Publicado 2019

Influenza Coinfection: Be(a)ware of Invasive Aspergillosis

por Verweij, Paul E, Brüggemann, Roger J M, Wauters, Joost, Rijnders, Bart J A, Chiller, Tom, van de Veerdonk, Frank L
Publicado 2020

Pharmacokinetics and Pharmacodynamics of Posaconazole

por Chen, Lu, Krekels, Elke H. J., Verweij, Paul. E., Buil, Jochem B., Knibbe, Catherijne A. J., Brüggemann, Roger J. M.
Publicado 2020

Pharmacokinetic Variability and Target Attainment of Fluconazole in Critically Ill Patients

por Van Daele, Ruth, Wauters, Joost, Lagrou, Katrien, Denooz, Raphaël, Hayette, Marie-Pierre, Gijsen, Matthias, Brüggemann, Roger J., Debaveye, Yves, Spriet, Isabel
Publicado 2021

Dose recommendations for gentamicin in the real-world obese population with varying body weight and renal (dys)function

por Smit, Cornelis, van Schip, Anne M, van Dongen, Eric P A, Brüggemann, Roger J M, Becker, Matthijs L, Knibbe, Catherijne A J
Publicado 2020

Oral antimicrobial agents in patients with short bowel syndrome: worth a try!

por Korzilius, Julia W, Gompelman, Michelle, Wezendonk, Guus T J, Jager, Nynke G L, Rovers, Chantal P, Brüggemann, Roger J M, Wanten, Geert J A
Publicado 2023

Optimization of flucloxacillin dosing regimens in critically ill patients using population pharmacokinetic modelling of total and unbound concentrations

por Jager, Nynke G L, van Hest, Reinier M, Xie, Jiao, Wong, Gloria, Ulldemolins, Marta, Brüggemann, Roger J M, Lipman, Jeffrey, Roberts, Jason A
Publicado 2020

Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing Strategies

por Jansen, Anouk M. E., Mertens, Beatrijs, Spriet, Isabel, Verweij, Paul E., Schouten, Jeroen, Wauters, Joost, Debaveye, Yves, ter Heine, Rob, Brüggemann, Roger J. M.
Publicado 2023